Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Swiss Association for the Study of the Liver"'
Autor:
Swiss Society of Gastroenterology, Swiss Society of Visceral Surgery, Swiss Association for the Study of the Liver, Swiss Society of Endoscopy Nurses and Associates
Publikováno v:
Swiss Medical Weekly, Vol 154, Iss 9 (2024)
Externí odkaz:
https://doaj.org/article/73f60f18b3bc45d3a337fb4331e1faad
Autor:
Swiss Society of Gastroenterology, Swiss Society of Visceral Surgery, Swiss Association for the Study of the Liver, Swiss Society of Endoscopy Nurses and Associates
Publikováno v:
Swiss Medical Weekly, Vol 153, Iss 9 (2023)
No abstract available.
Externí odkaz:
https://doaj.org/article/972e7c3d5a4e4117ba7a6f6e6bc93af6
Publikováno v:
Swiss Medical Weekly, Vol 142, Iss 0708 (2012)
Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma worldwide. Two first-generation protease inhibitors, telaprevir and boceprevir, have recently been approved for the treatment of c
Externí odkaz:
https://doaj.org/article/9a53284286714a88b5b8fc1d6edfe88c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
August-Jörg, B.S., Borovicka, J., Dufour, J.F., Gonvers, J.J., Henz, S., Hermann, R., Meyenberger, C., Weitz, M., Renner, E.L.
Publikováno v:
Swiss medical weekly, vol. 133, no. 33-34, pp. 455-460
Roughly 50% of patients with chronic hepatitis C, who relapsed after a previous monotherapy with interferon alpha, will respond in a sustained fashion to 24 weeks of re-therapy with the combination of interferon alpha plus ribavirin. Whether prolongi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f15386a1358d694647b172136bf6aa53
https://doi.org/10.4414/smw.2003.10300
https://doi.org/10.4414/smw.2003.10300